Optical treatment of amblyopia in older children and adults is essential prior to enrolment in a clinical trial

ConclusionsImprovements from optical treatment resulted in one‐fifth of participants becoming ineligible for the main clinical trial. Studies investigating additional amblyopia therapies must include an appropriate optical treatment only phase and/or parallel treatment group regardless of patient age. Optical treatment of amblyopia in adult patients warrants further investigation.

Source: Ophthalmic and Physiological Optics - January 1, 2018 Category: Opthalmology Authors: Tina Y. Gao, Nicola Anstice, Raiju J. Babu, Joanna M. Black, William R. Bobier, Shuan Dai, Cindy X. Guo, Robert F. Hess, Michelle Jenkins, Yannan Jiang, Lisa Kearns, Lionel Kowal, Carly S. Y. Lam, Peter C. K. Pang, Varsha Parag, Jayshree South, Sandra Elf Tags: Original Article Source Type: research